<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-110328</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Treatment of corpus uteri carcinoma through robot-assisted laparoscopy: Our preliminary results</dc:title>
<dc:description xml:lang="en">Objective. To present our experience from October 2009 though December 2011 and to compare outcomes and complications with a large study published in the American Journal of Obstetrics and Gynecology (AJOG) in 2011. Material and methods. We performed a prospective study of our first 55 corpus uteri carcinomas: 50 endometrioid adenocarcinomas, two papillary serous carcinomas and three Müllerian adenosarcomas, treated with robot-assisted laparoscopy (da Vinci) in the Basurto University Hospital from October 2009 through December 2011. The variables analyzed were age, body mass index, histologic type, stages, treatment, mean operating time, mean of number of lymph nodes retrieved, the mean number and percentage of involved lymph nodes, surgical bleeding and conversion to laparotomy. We also analyzed the number and the percentage of operative, post-operative and total complications. Results. The mean number of pelvic nodes was 14.44 vs. 13.16. Operating time was 181.1/286.5minutes vs 196.33minutes. Conversion to laparotomy was 5.45% vs. 2.9%. The percentage of total complications was 16.36% vs. 6.4%. Conclusions. 1) The number of pelvic nodes retrieved and the operating time were similar to those reported by the AJOG study. 2) Conversion to laparotomy and the percentage of total complications were higher than those reported in the AJOG study, possibly due to the smaller number of cases and the lesser experience (learning curve). 3) Robot-assisted laparoscopy is a viable approach with an excellent future in the treatment and staging of corpus uteri carcinomas(AU)</dc:description>
<dc:creator>Arriba Olivenza, Tania</dc:creator>
<dc:creator>Lobo Lafuente, Ignacio</dc:creator>
<dc:creator>Beiro Felipe, Eva</dc:creator>
<dc:creator>de la Rosa Fernández, Jesús Hilario</dc:creator>
<dc:creator>Andía Ortiz, Daniel</dc:creator>
<dc:creator>Lopez Valverde, Miguel</dc:creator>
<dc:creator>Ajuruagogeaskoa Andrada, Saioa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Presentación de nuestra experiencia desde octubre del 2009 hasta diciembre del 2011 y comparación de los resultados y las complicaciones con el amplio estudio publicado en el American Journal of Obstetrics and Gynecology (AJOG) en 2011. Material y métodos. Estudio prospectivo de nuestros primeros 55 carcinomas de cuerpo uterino: 50 adenocarcinomas endometrioides, 2 adenocarcinomas seroso-papilares de endometrio y 3 tumores müllerianos mixtos (TMM), tratados mediante laparoscopia asistida por robot (da Vinci) en el Hospital Universitario de Basurto desde octubre del 2009 hasta diciembre del 2011. Las variables analizadas han sido: edad, índice de masa corporal (IMC), tipos histológicos, estadios, tipos de tratamientos, medias del tiempo quirúrgico, media del número de ganglios obtenidos y número y porcentaje de ganglios invadidos, sangrado operatorio y conversiones a laparotomía. Así mismo, se han analizado el número y el porcentaje de las complicaciones intraoperatorias, postoperatorias y totales. Resultados. Media de ganglios pélvicos: 14,44 vs. 13,16. Tiempo operatorio: 181,1/286,5 min vs. 196,33 min. Conversión a laparotomía: 5,45% vs. 2,9%. Complicaciones totales: 16,36% vs. 6,4%. Conclusiones. 1) El número de ganglios pélvicos obtenidos y el tiempo operatorio son similares a los publicados en el estudio del AJOG; 2) la conversión a laparotomía y el porcentaje de complicaciones totales son superiores a los referidos en el estudio del AJOG, quizás debido al menor número de casos y a la menor experiencia (curva de aprendizaje); 3) la laparoscopia asistida por robot es una vía adecuada y con gran futuro en el tratamiento y la estadificación de los carcinomas de cuerpo uterino(AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);56(3): 135-139, mar. 2013.</dc:source>
<dc:identifier>ibc-110328</dc:identifier>
<dc:title xml:lang="es">Tratamiento del carcinoma de cuerpo uterino mediante laparoscopia asistida por robot: nuestros primeros resultados</dc:title>
<dc:subject>^d31595^s22009</dc:subject>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d14995^s29166</dc:subject>
<dc:subject>^d15000^s29166</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24542</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d30912^s22074</dc:subject>
<dc:subject>^d11622^s22054</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d19341^s22045</dc:subject>
<dc:subject>^d31595^s29166</dc:subject>
<dc:subject>^d19341^s22066</dc:subject>
<dc:subject>^d19341^s22049</dc:subject>
<dc:subject>^d11622^s22067</dc:subject>
<dc:subject>^d14995^s22067</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d30131^s29166</dc:subject>
<dc:subject>^d15000^s22053</dc:subject>
<dc:subject>^d11622^s29166</dc:subject>
<dc:subject>^d19341^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201303</dc:date>
</metadata>
</record>
</ibecs-document>
